FindMyKOL
Clinical trialNCT01620268TerminatedPhase 2Interventional

An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

SponsorChangzheng-CinkateEnrollment24ViremiaViruria
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the clinical efficacy and safety of a combination of leflunomide and orotic acid in kidney transplant patients with high levels of Polyoma BK viruria for the purpose of preventing Polyoma BK viremia and Nephropathy that could lead to kidney transplant loss from viral damage, acute rejection or both.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama, Birmingham

    Birmingham, Alabama, United States

  • Tampa General Hospital

    Tampa, Florida, United States

  • Rush Univeristy

    Chicago, Illinois, United States

  • the University of Chicago Transplant Center

    Chicago, Illinois, United States

  • University of Illinois, Chicago

    Chicago, Illinois, United States

  • Iu Health

    Indianapolis, Indiana, United States

  • University of Lousiville

    Louisville, Kentucky, United States

  • Beth Israel Deaconess Hospital

    Boston, Massachusetts, United States

  • Methodist University Hospital

    Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Leflunomide and orotic acid
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2012
Primary completion
30 Jun 2018
Completion
30 Jun 2018
Last update posted
5 Dec 2018
Registered enrollment
24
Registry id
NCT01620268
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.